Children are at greater risk than adults of permanent brain damage and mortality following head injury or infection [1] [2] [3] [4] [5] . Rodent models have demonstrated a 'window of susceptibility' in young animals during which the brain parenchyma is at greater risk of acute neutrophil-mediated breakdown of the blood-brain barrier [6, 7] . The exact mechanism of this age-related susceptibility to brain inflammation has yet to be defined, but animal models have revealed that the potent pro-inflammatory cytokine interleukin-1b (IL-1b) initiates an intense acute neutrophil-mediated inflammatory response in the brains of young rats and mice that is not seen in adults [6] . Here, we demonstrate the rapid induction of CXC chemokines (which contain a Cys-X-Cys motif), in particular the cytokine-induced neutrophil chemoattractant CINC-1, following the intracerebral administration of IL-1b. The CXC chemokines produced a more intense neutrophil response in young rats than in adults. The IL-1b-induced blood-brain barrier breakdown in young rats could be attenuated by an anti-CINC-1 neutralising antibody. These results show that the immature central nervous system (CNS) is dramatically more susceptible to the chemotactic effects of CXC chemokines. Blocking the CXC chemokine activity associated with brain inflammation inhibits neutrophil-mediated blood-brain barrier damage and represents a significant therapeutic possibility.
Results and discussion
The early expression of CXC chemokines that induce neutrophil chemotaxis was examined in adult and juvenile rat brain to see whether these chemokines might underlie the acute pro-inflammatory effects of IL-1β. A competitive reverse transcriptase (RT)-PCR assay [8] was used to determine the level of acute mRNA expression for the rat CXC chemokines CINC-1 and macrophage inhibitory protein-2 (MIP-2) following intra-cerebral administration of rat recombinant (rr) IL-1β [9, 10] . After extracting mRNA, the cDNA was reverse transcribed from it and amplified by PCR in the presence of known concentrations of a synthetic standard plasmid containing primer sites for rat β-actin, CINC-1 and MIP-2 that yielded products distinguishable by size from the PCR products copied from the reverse-transcribed mRNA (see Supplementary material, published with this paper on the internet). The assay revealed a rapid increase in both MIP-2 and CINC-1 mRNAs in the groups of rats treated with IL-1β, whereas these mRNAs were virtually undetectable in saline-treated controls ( Figure 1a ). CINC-1 mRNA, in particular, showed a 10,000-fold increase in expression in IL-1β-treated brain. Using a rat CINC-1 enzyme-linked immunosorbent assay (ELISA) we found that CINC-1-like immunoreactivity was also increased in adult and juvenile rats 4 hours following IL-1β administration (Figure 1b ).
Despite previous demonstrations of more intense IL-1β-induced neutrophil recruitment and blood-brain barrier breakdown in juvenile rats [6] , the experiments described above indicate that the expression of CXC chemokines, particularly CINC-1, occurs rapidly and to much the same level in the brains of adults and juveniles. We therefore examined whether, like IL-1β, the intra-cerebral administration of CXC chemokines would precipitate a different pattern of responses in adult and juvenile brains. Striking age-related differences were observed in the effects of both rrCINC-1 and rrMIP-2 ( Figure 2 ). Whereas in control rats the microinjection of vehicle produced no neutrophil recruitment or blood-brain barrier breakdown measured as horseradish peroxidase (HRP) extravasation, microinjection of CINC-1 induced profound HRP extravasation and neutrophil recruitment as early as 4 hours following its administration to juvenile rat brain (Figures 2a,3a,3c ). Adult rats showed significantly less neutrophil recruitment and HRP extravasation at the 4 hour time-point (Figures 2b,3a,3c ). CINC-1-induced neutrophil recruitment was observed in adult rats, particularly at 12 hours after CINC-1 administration ( Figure 3a) ; the overall neutrophil response was lower and delayed (analysis of variance, p < 0.05), however, compared with juveniles. HRP extravasation following CINC-1 administration was rapid and extensive in juveniles, showing a gradual decline over 24 hours (Figure 3c ). In adults, however, HRP extravasation was almost absent at the early time-points and never reached the maximal response displayed in juvenile brain (Figure 3c ). MIP-2 also induced a more intense response in juvenile rats than in adults, although in comparison with CINC-1 the onset of neutrophil recruitment and HRP extravasation induced by MIP-2 was delayed (Figures 2c,3b,3c) . In contrast to the rapid and widespread effects of CINC-1, MIP-2 induced intense, but focal, neutrophil recruitment to the striatum from 12 to 24 hours following its administration (Figure 3b ). MIP-2 induced less HRP extravasation than CINC-1 (Figure 3c ). In keeping with the putative neutrophil-selective chemotactic effects of these CXC chemokines, almost all the leukocytes that were recruited within the 24 hours following the administration of CINC-1 and MIP-2 were neutrophils (Figure 3a,b) . The HRP extravasation induced by both CINC-1 and MIP-2 was also neutrophil-dependent, because it was inhibited following the depletion of circulating neutrophils with an anti-neutrophil antiserum ( Figure 2d ).
Given these results, we decided to test whether the intense inflammatory response and blood-brain barrier breakdown induced by IL-1β in juvenile rats could be attenuated by the administration of an anti-rat CINC-1 neutralising antibody. Juvenile rats treated with IL-1β plus a control non-specific rabbit immunoglobulin G (IgG) displayed a brain inflammatory response 4 hours following treatment that was comparable to that previously described for IL-1β [6] (Figures 2e,4) . The IL-1β-treated brains showed extensive blood-brain barrier breakdown with concomitant intraparenchymal neutrophil recruitment. Injection of the non-specific rabbit IgG or the anti-CINC-1 neutralising antibody alone did not produce an inflammatory response ( Figure 4a ). In marked contrast, animals treated with IL-1β plus the Microinjection of rrIL-1β (1 ng) into adult or juvenile rat striatum induces expression of CXC chemokines. (a) Quantitation of rat CINC-1 and MIP-2 mRNA (measured via quantitation of cDNA) in rat striatum 4 h following the injection of rrIL-1β or saline. The ratio of standard cDNA to cellular cDNA was plotted on a log-log scale against the dilution of standard. The dilution value when the ratio of standard to cellular cDNA was equal to 1 was calculated [8] . Log mean ± SEM (n = 3 rats per group) cDNA levels are expressed as a percentage of β-actin cDNA levels for each sample. An asterisk denotes a significant difference (p < 0.01) between the IL-1-treated and saline-treated groups. (b) Expression of rat CINC-1-like immunoreactivity 4 h following IL-1β or saline administration to adult and juvenile rat striatum (mean ± SEM; n = 4 rats per group). An ELISA (rat CINC-1 ELISA kit, IBL [11] ) of each sample was carried out in triplicate and quantitation of CINC-1-like immunoreactivity was determined using a standard curve of rrCINC-1. Blood-brain barrier breakdown induced by CXC chemokines in adult and juvenile rat brain measured by HRP extravasation. (a) Juvenile (3-week-old) and (b) adult (3-month-old) rat brains 4 h following an intra-striatal injection of 0.5 µg rrCINC-1 (n = 3 rats per group). The extent of HRP extravasation in juvenile rat brain 12 h following CINC-1 administration was similar to that at 4 h (see Figure 3c) . anti-CINC-1 neutralising antibody showed a significant reduction in neutrophil recruitment and almost complete absence of HRP extravasation (Figures 2f,4 ).
These results demonstrate that the intense neutrophil recruitment and concomitant blood-brain barrier breakdown induced by IL-1β in the brains of juvenile rats is largely accounted for by an increased susceptibility to the neutrophil chemotactic effects of CXC chemokines. An anti-rat CINC-1 neutralising antibody significantly inhibited both neutrophil recruitment to the juvenile brain parenchyma and IL-1β-induced HRP extravasation. The latter finding is consistent with the previous demonstration that IL-1β-induced HRP extravasation in juvenile rats is neutrophil dependent [6] . Yamasaki et al. [11] have also demonstrated that systemic administration of an anti-CINC-1 neutralising antibody can reduce increases in brain water content following ischemic reperfusion injury in adult rats. The increased neutralising effect of the anti-CINC-1 antibody seen in this study compared with that of Yamasaki et al. [11] is likely to be due to IL-1β-induced chemokine synthesis and presentation by CNS cells, such as astrocytes [12] .
The induction of cytokines by CNS cells has been reported in conjunction with many different neuropathologies [13, 14] . Nevertheless, experiments in rats and mice have shown that IL-1β-induced leukocyte recruitment and plasma extravasation in the adult brain parenchyma is slower and attenuated compared with that seen in peripheral tissues [15] . This inherent resistance to brain inflammation offers a direct advantage to the host in terms of protecting neural tissue from permanent damage. Comparison of the dose-response relationships for IL-1β-induced Inflammation and blood-brain barrier breakdown induced by CXC chemokines in adult and juvenile rat brain. Leukocyte recruitment to adult and juvenile striatum, measured at the intervals shown, following an injection of (a) rrCINC-1 (0.5 µg) or (b) rrMIP-2 (0.5 µg). Polymorphonuclear neutrophils were identified using a rat polyclonal anti-neutrophil antibody (ANS) [18] . Macrophages were identified using the monoclonal antibody ED1 (donated by the Dunn School of Pathology). (c) HRP extravasation in adult and juvenile brain 4 h following an injection of rrCINC-1 (0.5 µg) or rrMIP-2 (0.5 µg). An asterisk denotes a significant difference between the respective adult and juvenile groups (mean ± SEM; n = 3 rats per group; t test, p < 0.05).
Figure 4
Inhibitory effects of an anti-CINC-1 neutralising antibody on inflammation and blood-brain barrier breakdown in juvenile rats. inflammation in the brains of young and adult rats, however, indicates that the brains of young rats are more susceptible to the inflammatory effects of IL-1β [6, 7] . Neither the postnatal development of the blood-brain barrier nor the differential expression of adhesion molecules mediate these age-related differences [6, 7, 16] . The inhibition of blood-brain barrier breakdown by the depletion of circulating neutrophils or by an anti-CINC-1 neutralising antibody clearly shows, however, that it is the neutrophil chemotactic effects of CXC chemokines that are most destructive to the juvenile rat brain.
Once in the brain, neutrophils are potent contributors to the acute inflammatory response and can promote neural injury. This has been clearly demonstrated in transgenic mice expressing the CXC chemokine N51/KC in brain oligodendrocytes [17] . Neutrophil-mediated blood-brain barrier breakdown is a mechanism by which CNS tissue can be damaged. Neurological studies have demonstrated that alterations in blood-brain barrier breakdown permeability, and cerebral oedema in children and infants with bacterial meningitis, are directly associated with poor prognosis [5] . Several clinical studies have noted the increased risk of permanent brain damage and poor prognosis following head injury or cerebral infection in young children [4, 5] . Mortality rates following head injury are much higher in children [3] and acute infections, such as meningitis and malaria, are not only more frequent but also more severe in young children than in adults [1, 2] . Clearly, if the childhood risks associated with brain injury and infection are due to an increased susceptibility to neutrophil-mediated brain inflammation then the prevention of neutrophil recruitment to the brain by antagonising the effects of CXC chemokines would represent a significant therapeutic possibility.
Materials and methods
Wistar rats (Charles River) received intra-striatal microinjections (maximum volume, 1 µl) as described [6] . Rat recombinant IL-1β (National Institute for Biological Standards and Controls) was dissolved in a solution of 0.1% bovine serum albumin in PBS, or mixed with an anti-rat CINC-1 neutralising antibody (Peprotech) or rabbit IgG (Serotec). Rat recombinant MIP-2 and CINC-1 (Peprotech) were freshly made up from lyophilised protein immediately before use, and dissolved in sterile filtered 0.9% saline. Assessment of the blood-brain barrier with type II HRP (Sigma), 10 4 U/kg, as a bloodborne tracer was carried out as described [6] . Quantitation of the area of HRP extravasation from brain sections was calculated using Optilab 2.1 for Macintosh software (Graphtec). Immunohistochemistry was used to confirm the presence and distribution of specific cell populations [6] . For PCRs and ELISAs, rats were killed 4 h following IL-1β administration, brains were removed and the striatums from the injected hemisphere were dissected and quickly frozen in liquid nitrogen. A neutrophil-depleting antiserum (Acurate) was used to deplete circulating neutrophils in 3-week-old rats, as described [6] , and resulted in profound neutrophil depletion.
Supplementary material
A table showing primer sequences and amplicon lengths for the competitive RT-PCR assay is published with this paper on the internet. 
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